---
input_text: 'Molecular Monitoring of Allogeneic Stem Cell Transplantation in Fanconi
  Anemia. BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) is
  the treatment of choice in patients with Fanconi anemia (FA). The aim of our study
  is to evaluate the impact and benefits of allogenic matched donor HSCT in a case
  of a 12 year-old girl with FA, who displayed good clinical evolution following 2
  months post-transplantation. METHODS: In the pre-transplant phase, reference blood
  samples from the donor and recipient were collected on EDTA. The DNA from blood
  samples was extracted using an automated Maxwell  48 RSC instrument (Promega, USA)
  with the Maxwell  RSC Whole blood DNA kit (Promega, USA). For DNA quantification,
  the PowerQuant System kit (Promega, USA) was used with the ABI 7500 Real-time PCR
  system (Applied Biosystems, USA). The amplification of the short tandem repeat markers
  was performed using the 24plex Investigator QS kit (Qiagen, Germany) on a ProFlex
  PCR System. Furthermore, the PCR products were separated and detected on an ABI
  3500 Genetic Analyzer (Applied Biosytems, USA). RESULTS: Thirty days post transplantation,
  a complete chimerism (CC) was achieved with a full replacement by do-nor derived
  hematopoietic cells. Sixty days post transplantation, the CC status was maintained
  with improvement of hematological findings. CONCLUSIONS: In FA, chimerism monitoring
  after HSCT provides useful information regarding engraftment or possibility of post-transplantation
  complications such as graft versus host disease.'
raw_completion_output: |-
  primary_disease: Fanconi anemia
  medical_actions: Allogeneic hematopoietic stem cell transplantation (HSCT);Molecular monitoring;Complete chimerism achievement;Improvement of hematological findings
  symptoms: 
  chemicals: EDTA
  action_annotation_relationships: Allogeneic hematopoietic stem cell transplantation (HSCT) TREATS Fanconi anemia;Molecular monitoring PREVENTS graft versus host disease IN Fanconi anemia;Complete chimerism achievement INDICATES successful treatment IN Fanconi anemia;Improvement of hematological findings INDICATES recovery IN Fanconi anemia
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Improvement of hematological findings INDICATES recovery IN Fanconi anemia

  ===

extracted_object:
  primary_disease: MONDO:0019391
  medical_actions:
    - MAXO:0000747
    - Molecular monitoring
    - Complete chimerism achievement
    - Improvement of hematological findings
  chemicals:
    - CHEBI:4735
  action_annotation_relationships:
    - subject: MAXO:0001479
      predicate: TREATS
      object: Fanconi anemia
    - subject: Molecular monitoring
      predicate: PREVENTS
      object: graft versus host disease
      qualifier: MONDO:0019391
    - subject: Complete chimerism achievement
      predicate: INDICATES
      object: successful treatment
      qualifier: MONDO:0019391
    - subject: Improvement of hematological findings
      predicate: INDICATES
      object: recovery
      qualifier: MONDO:0019391
named_entities:
  - id: MONDO:0019391
    label: Fanconi anemia
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation (HSCT)
  - id: CHEBI:18198
    label: ADCs
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: MAXO:0000750
    label: conditioning regimens
  - id: CHEBI:37153
    label: Calcineurin inhibitor
  - id: CHEBI:38215
    label: Calcium channel blocker
  - id: CHEBI:4031
    label: Cyclosporine
  - id: CHEBI:8069
    label: Phenobarbital
  - id: CHEBI:2668
    label: Amlodipine
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: MAXO:0000016
    label: Cellular therapy
  - id: HP:0001871
    label: Blood dyscrasias
  - id: MAXO:0000595
    label: Radiography
  - id: HP:0005528
    label: Bone marrow failure
  - id: HP:0034057
    label: Congenital defects
  - id: CHEBI:28901
    label: Busulfan
  - id: CHEBI:44185
    label: Methotrexate
  - id: MONDO:0005233
    label: Non-small cell lung cancer (NSCLC)
  - id: CHEBI:33364
    label: Platinum
  - id: MAXO:0000647
    label: chemotherapy
  - id: HP:0030358
    label: Non-small cell lung cancer
  - id: MAXO:0001479
    label: Allogeneic hematopoietic stem cell transplantation (allo-HSCT)
  - id: HP:0002863
    label: Myelodysplasia
  - id: HP:0001909
    label: Leukemia
  - id: MONDO:0016624
    label: Hereditary anemia
  - id: MAXO:0001001
    label: Gene therapy
  - id: MONDO:0005570
    label: Hematological disorders
  - id: HP:0002664
    label: cancer
  - id: MONDO:0015253
    label: Diamond Blackfan anemia
  - id: MAXO:0000600
    label: Kidney replacement therapy (KRT)
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0003259
    label: Elevated serum creatinine (SCr > 100micromol/l)
  - id: MONDO:0001529
    label: Bone marrow failure (BMF)
  - id: HP:0002860
    label: oral squamous cell carcinoma (SCC)
  - id: MONDO:0100339
    label: Fanconi anemia (FA)
  - id: CHEBI:28680
    label: Ara-C
  - id: CHEBI:27899
    label: Cisplatin
  - id: HP:0011793
    label: Malignant tumors
  - id: HP:0000818
    label: Endocrinopathies
  - id: HP:0002745
    label: Oral leukoplakia
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:61049
    label: Tacrolimus
  - id: HP:0002910
    label: elevated liver function tests
  - id: CHEBI:125354
    label: plerixafor
  - id: CHEBI:231614
    label: Nivolumab
  - id: CHEBI:25016
    label: PBS
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:28876
    label: Melphalan
  - id: CHEBI:229764
    label: Selinexor
  - id: CHEBI:229762
    label: Eltanexor
  - id: HP:0006775
    label: Multiple Myeloma
  - id: CHEBI:229763
    label: exportin 1 inhibitors
  - id: MONDO:0015909
    label: aplastic anemia
  - id: HP:0004808
    label: Acute myeloid leukaemia
  - id: MAXO:0000004
    label: Surgery
  - id: MAXO:0000014
    label: Radiotherapy
  - id: MONDO:0001881
    label: Septic shock
  - id: MAXO:0001021
    label: Antimicrobial treatment
  - id: MAXO:0000174
    label: Antifungal treatment
  - id: HP:0001876
    label: Pancytopenia
  - id: HP:0001945
    label: Fever
  - id: CHEBI:133748
    label: Citrate
  - id: CHEBI:41879
    label: Dexamethasone
  - id: CHEBI:33281
    label: Antimicrobial
  - id: CHEBI:35718
    label: Antifungal
  - id: MONDO:0044033
    label: Posterior reversible encephalopathy syndrome (PRES)
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: MAXO:0001188
    label: Laparoscopy
  - id: HP:0000988
    label: Skin rash
  - id: MONDO:0010161
    label: Tyrosinemia Type 1
  - id: HP:0001919
    label: acute kidney injury (AKI)
  - id: HP:0000822
    label: hypertension
  - id: MAXO:0001298
    label: therapy
  - id: HP:0040012
    label: Increased chromosomal breakage
  - id: MONDO:0004631
    label: Tongue cancer (TC)
  - id: CHEBI:4735
    label: EDTA
